Home › Funds › Coppell Advisory Solutions LLC › NVCR

Coppell Advisory Solutions LLC position in NVCR

NOVOCURE LTD · Health Care

Coppell Advisory Solutions LLC reported holding 38,953 shares of NVCR (NOVOCURE LTD) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.40% of its reported portfolio and ranking #50 among its reported holdings. Coppell Advisory Solutions LLC has disclosed NVCR holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)38.95K sh
Reported value held$4.86M
Portfolio Weight0.40%
First reportedQ2 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Coppell Advisory Solutions LLC's NVCR position evolved

Coppell Advisory Solutions LLC first disclosed a stake in NVCR in Q2 2024 at 910 shares (US$16K). The position peaked in Q2 2026 at 38,953 shares, worth US$4.9M. Across 4 filings, Coppell Advisory Solutions LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 38,953 shares valued at US$4.9M. Notable position changes include a 93% trim in Q4 2024 (shares fell 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 910 $15.59K New
Q3 2024 1.12K $17.55K Add
Q4 2024 76 $2.29K Reduce
Q2 2026 38.95K $4.86M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCR and 13F data

NVCR (NOVOCURE LTD) is a Health Care company. 32 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M), C WorldWide Group Holding A/S (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCR

All NVCR fund holders →

FAQ

How long has Coppell Advisory Solutions LLC held NVCR?

Coppell Advisory Solutions LLC has disclosed NVCR holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

What is Coppell Advisory Solutions LLC's current position in NVCR?

As of Q2 2026, Coppell Advisory Solutions LLC holds 38.95K shares of NVCR (NOVOCURE LTD), valued at $4.86M, representing 0.40% of its reported portfolio and ranking #50.

Has Coppell Advisory Solutions LLC been buying or selling NVCR?

In the latest 13F filing (Q2 2026), Coppell Advisory Solutions LLC newly opened its position in NVCR. The position peaked in Q2 2026 at 38.95K shares.

Which other funds hold NVCR?

Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, C WorldWide Group Holding A/S, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.